Europlasma S.A. (LON:0W8R)
0.0043
0.00 (0.00%)
At close: Jul 31, 2025
PetIQ Revenue
In the year 2024, Europlasma had annual revenue of 42.82M EUR with 177.25% growth. Europlasma had revenue of 27.23M in the half year ending December 31, 2024, with 272.45% growth.
Revenue
42.82M EUR
Revenue Growth
+177.25%
P/S Ratio
0.12
Revenue / Employee
107.58K EUR
Employees
398
Market Cap
4.39M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 42.82M | 27.37M | 177.25% |
Dec 31, 2023 | 15.44M | 553.00K | 3.71% |
Dec 31, 2022 | 14.89M | 3.65M | 32.51% |
Dec 31, 2021 | 11.24M | 4.65M | 70.65% |
Dec 31, 2020 | 6.59M | 3.29M | 99.73% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Shell | 198.54B |
Unilever | 51.24B |
British American Tobacco p.l.c. | 25.60B |
Rolls-Royce Holdings | 19.54B |
Rio Tinto Group | 39.22B |
RELX PLC | 9.53B |